Meeting
2018 ASCO Annual Meeting
Association of high CD8+ tumor infiltrating lymphocytes at prostatectomy with improved survival of prostate cancer patients.
Authors
Yuanquan Yang
Roswell Park Comprehensive Cancer Center, Buffalo, NY
Yuanquan Yang , Kristopher Attwood , Cassandra Versaggi , Angela Omilian , Wiam Bshara , Bo Xu , Eric Kauffman , James Mohler , Khurshid Guru , Qiang Li , Saby George , Per Basse , Carl Morrison , Antonios Papanicolau-Sengos , Pawel Kalinski , Gurkamal S. Chatta
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Genitourinary (Prostate) Cancer
Track
Genitourinary Cancer—Prostate, Testicular, and Penile
Sub Track
Epidemiology/Outcomes
Citation
J Clin Oncol 36, 2018 (suppl; abstr 5068)
DOI
10.1200/JCO.2018.36.15_suppl.5068
Abstract #
5068
Poster Bd #
295
Abstract Disclosures
Similar Posters
Poster
2017 Genitourinary Cancers Symposium
Does higher number of lymph nodes (LNs) excised during radical prostatectomy (RP) improve biochemical relapse-free survival (bRFS) in patients with pT2-3a/pN0 prostate cancer?
First Author: Steven Neema Seyedin
Poster
2023 ASCO Annual Meeting
Depth of PSA nadir and subsequent PSA progression-free survival in patients (pts) with high-risk biochemically relapsed prostate cancer: Results from the phase 3 PRESTO study (AFT-19).
First Author: Rahul Raj Aggarwal
Poster
2023 ASCO Genitourinary Cancers Symposium
Length and Gleason pattern at positive surgical margin after radical prostatectomy to assess risk of postoperative recurrence in localized prostate cancer.
First Author: Masashi Kato
Poster
2023 ASCO Genitourinary Cancers Symposium
Validation of baseline health-related quality of life as prognostic indicator for survival outcome in men with intermediate risk prostate cancer undergoing radical prostatectomy.
First Author: Thilo Westhofen